Market Overview

pSivida Reports Second Phase 3 Study For Durasert Showed 'Highly Significant Difference Between Durasert and Sham in Prevention of Uveitis Recurrence at 12 Months'


This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Posted-In: FDA


Related Articles (PSDV)

Lightning Fast
Market News Service
$199 Free 14 Day Trial

Tesla Reports Q4 Earnings Beat, Record Vehicle Deliveries

Wealthfront's Head Of Design Offers Her 2018 Fintech Predictions